Epileptic activity is a surrogate for an underlying etiology and stopping the activity has a limited impact on developmental outcome

Epilepsia

Volumn 56, Issue 10, 2015, Pages 1477-1481

  Korff, Christian M ^a   Brunklaus, Andreas ^b   Zuberi, Sameer M ^b,c  

^a University Hospital   (Switzerland)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Childhood; Encephalopathy; Epileptic activity

Indexed keywords

AGE; ARTICLE; BRAIN DISEASE; COMORBIDITY; DEVELOPMENTAL DISORDER; DISEASE CONTROL; DISEASE COURSE; DISEASE MARKER; EPILEPSY; EPILEPTIC DISCHARGE; EPILEPTOGENESIS; GENETIC VARIABILITY; HUMAN; INTELLECTUAL IMPAIRMENT; NERVE CELL NETWORK; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; ANIMAL; COGNITION DISORDERS; COMPLICATION; DEVELOPMENTAL DISABILITIES; GENETICS; INTELLECTUAL DISABILITY; MOUSE;

ANIMALS; BRAIN DISEASES; COGNITION DISORDERS; DEVELOPMENTAL DISABILITIES; EPILEPSY; HUMANS; INTELLECTUAL DISABILITY; MICE;

EID: 84943197479     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.13105     Document Type: Article

References (35)

1. Berg AT, Berkovic SF, Brodie MJ, et al., Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010; 51: 676-685.
2. Inoue Y, Fujiwara T, Matsuda K, et al., Ring chromosome 20 and nonconvulsive status epilepticus. A new epileptic syndrome. Brain 1997; 120: 939-953.
3. Lux AL,. Is hypsarrhythmia a form of non-convulsive status epilepticus in infants? Acta Neurol Scand 2007; 115: 37-44.
4. Dulac O, Chiron C, Robain O, et al., Infantile spasms: a pathophysiological hypothesis. Semin Pediatr Neurol 1994; 1: 83-89.
5. Osborne JP, Lux AL, Edwards SW, et al., The underlying etiology of infantile spasms (West syndrome): information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification. Epilepsia 2010; 51: 2168-2174.
6. Koo B, Hwang PA, Logan WJ,. Infantile spasms: outcome and prognostic factors of cryptogenic and symptomatic groups. Neurology 1993; 43: 2322-2327.
7. Darke K, Edwards SW, Hancock E, et al., Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial. Arch Dis Child 2010; 95: 382-386.
8. Dravet C,. How Dravet syndrome became a model for studying childhood genetic epilepsies. Brain 2012; 135: 2309-2311.
9. Wolff M, Casse-Perrot C, Dravet C,. Severe myoclonic epilepsy of infants (Dravet syndrome): natural history and neuropsychological findings. Epilepsia 2006; 47: S45-S48.
10. Zuberi SM, Brunklaus A, Birch R, et al., Genotype-phenotype associations in SCN1A-related epilepsies. Neurology 2011; 76: 594-600.
11. Ogiwara I, Miyamoto H, Morita N, et al., Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J Neurosci 2007; 27: 5903-5914.
12. Yu FH, Mantegazza M, Westenbroek RE, et al., Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci 2006; 9: 1142-1149.
13. Catterall WA, Goldin AL, Waxman SG,. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev 2005; 57: 397-409.
14. Han S, Tai C, Westenbroek RE, et al., Autistic-like behaviour in Scn1a+/- mice and rescue by enhanced GABA-mediated neurotransmission. Nature 2012; 489: 385-390.
15. Bender AC, Natola H, Ndong C, et al., Focal Scn1a knockdown induces cognitive impairment without seizures. Neurobiol Dis 2013; 54: 297-307.
16. Brunklaus A, Zuberi SM,. Dravet syndrome-from epileptic encephalopathy to channelopathy. Epilepsia 2014; 55: 979-984.
17. Oliver KL, Lukic V, Thorne NP, et al., Harnessing gene expression networks to prioritize candidate epileptic encephalopathy genes. PLoS ONE 2014; 9: e102079.
18. De Vivo DC, Trifiletti RR, Jacobson RI, et al., Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 1991; 325: 703-709.
19. Leen WG, Klepper J, Verbeek MM, et al., Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 2010; 133 (Pt 3): 655-670.
20. Arsov T, Mullen SA, Rogers S, et al., Glucose transporter 1 deficiency in the idiopathic generalized epilepsies. Ann Neurol 2012; 72: 807-815.
21. Ramm-Pettersen A, Stabell KE, Nakken KO, et al., Does ketogenic diet improve cognitive function in patients with GLUT1-DS? A 6- to 17-month follow-up study. Epilepsy Behav 2014; 39: 111-115.
22. Guerrini R, Dravet C, Genton P, et al., Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia 1998; 39: 508-512.
23. Brunklaus A, Ellis R, Reavey E, et al., Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome. Brain 2012; 135: 2329-2336.
24. Larsen J, Carvill GL, Gardella E, et al., The phenotypic spectrum of SCN8A encephalopathy. Neurology 2015; 84: 480-489.
25. Wright CF, Fitzgerald TW, Jones WD, et al., Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data. Lancet 2014; 385: 1305-1314.
26. Johnson MR, Shorvon SD,. Heredity in epilepsy: neurodevelopment, comorbidity, and the neurological trait. Epilepsy Behav 2011; 22: 421-427.
27. Berg AT, Smith SN, Frobish D, et al., Special education needs of children with newly diagnosed epilepsy. Dev Med Child Neurol 2005; 47: 749-753.
28. Engel J Jr,. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001; 42: 796-803.
29. Zuberi SM, O'Regan ME,. Developmental outcome in benign myoclonic epilepsy in infancy and reflex myoclonic epilepsy in infancy: a literature review and six new cases. Epilepsy Res 2006; 70: S110-S115.
30. Grinton BE,. Benign familial neonatal seizures associated with KCNQ2 mutations. Epilepsia (in press 2015).
31. Milh M, Boutry-Kryza N, Sutera-Sardo J, et al., Similar early characteristics but variable neurological outcome of patients with a de novo mutation of KCNQ2. Orphanet J Rare Dis 2013; 8: 80.
32. Lesca G, Rudolf G, Bruneau N, et al., GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction. Nat Genet 2013; 45: 1061-1066.
33. Carvill GL, Regan BM, Yendle SC, et al., GRIN2A mutations cause epilepsy-aphasia spectrum disorders. Nat Genet 2013; 45: 1073-1076.
34. Lemke JR, Lal D, Reinthaler EM, et al., Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet 2013; 45: 1067-1072.
35. Caraballo RH, Veggiotti P, Kaltenmeier MC, et al., Encephalopathy with status epilepticus during sleep or continuous spikes and waves during slow sleep syndrome: a multicenter, long-term follow-up study of 117 patients. Epilepsy Res 2013; 105: 164-173.